1. Ge, Xueling, Jiang, Wei, Jiang, Yujie, Liu, Xin, Wang, Xin. 2020. Expression and Importance of TMED2 in Multiple Myeloma Cells. In Cancer management and research, 12, 12895-12903. doi:10.2147/CMAR.S278570. https://pubmed.ncbi.nlm.nih.gov/33364837/
2. Anwar, Muhammad U, Sergeeva, Oksana A, Abrami, Laurence, D'Angelo, Giovanni, van der Goot, F Gisou. 2022. ER-Golgi-localized proteins TMED2 and TMED10 control the formation of plasma membrane lipid nanodomains. In Developmental cell, 57, 2334-2346.e8. doi:10.1016/j.devcel.2022.09.004. https://pubmed.ncbi.nlm.nih.gov/36174556/
3. Liang, Chen, Zhang, Han-Yong, Wang, Yi-Qian, Zhang, Tong-Cun, Xu, Yao. 2023. TMED2 Induces Cisplatin Resistance in Breast Cancer via Targeting the KEAP1-Nrf2 Pathway. In Current medical science, 43, 1023-1032. doi:10.1007/s11596-023-2777-7. https://pubmed.ncbi.nlm.nih.gov/37615927/
4. Hou, Wenyang, Jerome-Majewska, Loydie A. 2018. TMED2/emp24 is required in both the chorion and the allantois for placental labyrinth layer development. In Developmental biology, 444, 20-32. doi:10.1016/j.ydbio.2018.09.012. https://pubmed.ncbi.nlm.nih.gov/30236446/
5. Gao, Wen, Zhang, Zhe-Wen, Wang, Hong-Yi, Liao, Yu-Xuan, Liu, An. 2022. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma. In Frontiers in genetics, 13, 895281. doi:10.3389/fgene.2022.895281. https://pubmed.ncbi.nlm.nih.gov/35754792/
6. Zakariyah, A, Hou, W, Slim, R, Jerome-Majewska, L. 2011. TMED2/p24β1 is expressed in all gestational stages of human placentas and in choriocarcinoma cell lines. In Placenta, 33, 214-9. doi:10.1016/j.placenta.2011.12.009. https://pubmed.ncbi.nlm.nih.gov/22212250/
7. Sun, Ming-Shun, Zhang, Jie, Jiang, Li-Qun, Shu, Hong-Bing, Liu, Yu. . TMED2 Potentiates Cellular IFN Responses to DNA Viruses by Reinforcing MITA Dimerization and Facilitating Its Trafficking. In Cell reports, 25, 3086-3098.e3. doi:10.1016/j.celrep.2018.11.048. https://pubmed.ncbi.nlm.nih.gov/30540941/
智鼠故事 
